semaglutide cause bone loss Once-weekly versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial New studies have raised fresh

Self-administration of such products is strongly discouraged and may carry serious health consequences

They do not produce androgenic effects

The same study also found that: 90.7% of people lose at least 5% of their starting weight 82.4% of people lose at least 10% of their starting weight 66.5% of people lose at least 15% of their starting weight 47.7% of people lose at least 20% of their starting weight 31.2% of people lose at least 25% of their starting weight On the Wegovy tablet, clinical trials have found that people lose an average 17% of their starting weight

Both ingredients are active, both can cause initial irritation, and using them simultaneously may overwhelm sensitive skin